Twitter | Search | |
bluebird bio
bluebird bio is developing innovative gene therapies for severe genetic disorders. Our vision is to make the hope of gene therapy a reality.
613
Tweets
670
Following
3,103
Followers
Tweets
bluebird bio 14h
Reply Retweet Like
bluebird bio 17h
Tomorrow is ! It's our 6th year participating in this great event to support and we are PUMPED!
Reply Retweet Like
bluebird bio 18h
Ouch... sick burn! But we still have two more days!
Reply Retweet Like
bluebird bio retweeted
Mark Bonica 19h
Alexandra Miller '12 talking about her career at Boston Day
Reply Retweet Like
bluebird bio Mar 23
Reply Retweet Like
bluebird bio Mar 22
We're just a *little* competitive. And we love supporting !
Reply Retweet Like
bluebird bio Mar 21
The birds never give up! BRING IT!
Reply Retweet Like
bluebird bio Mar 21
Who's that storming up the leaderboard for ? We're coming for you, !
Reply Retweet Like
bluebird bio Mar 20
bluebird welcomes new manufacturing and corporate development executives to the flock!
Reply Retweet Like
bluebird bio Mar 17
Reply Retweet Like
bluebird bio Mar 17
Reply Retweet Like
bluebird bio Mar 15
Thank you for visiting us and sharing your story - you are such an inspiration!
Reply Retweet Like
bluebird bio Mar 1
Today, we announced that has published a case study on a patient w/ in our HGB-205 clinical trial:
Reply Retweet Like
bluebird bio Feb 22
announces Q4 and FY 2016 financial results and recent operational progress:
Reply Retweet Like
bluebird bio retweeted
Mariana Fagnilli Feb 22
engaging discussion on improving access to rare disease therapies
Reply Retweet Like
bluebird bio Feb 3
announces treatment of first patient with severe sickle cell disease under amended HGB-206 study protocol
Reply Retweet Like
bluebird bio Jan 5
The birds fly off to in just a few days! We hope to see you there.
Reply Retweet Like
bluebird bio Dec 15
and apceth Biopharma announce commercial drug product manufacturing agreement
Reply Retweet Like
bluebird bio Dec 14
announces that the first patient has been treated in the Phase 3 Northstar-2 trial of LentiGlobin
Reply Retweet Like
bluebird bio Dec 3
announces updated data from HGB-205 study of LentiGlobin
Reply Retweet Like